文献速递主动脉疾病颈动脉与弓上血管

RELAY 家族:单分支支架国际结局研究

From the RELAY Family-A Story of Single-Branched International Outcomes.
PubMed 文献 · Ann Vasc Surg · 2022-09-28

本研究前瞻性收集并回顾性分析2019年1月至2022年1月欧洲多中心17例接受单分支 RELAY™ 腔内移植物治疗的患者数据,评估技术成功、术后结局及再干预率。17例技术成功率达100%,随访24个月靶血管通畅率93.7%,无致残或非致残性卒中、再干预或死亡。作者认为该单分支支架治疗主动脉弓病变具有可行性。

要点

  • 17例单分支 RELAY 支架技术成功率为100%。
  • 术后30天靶血管通畅率100%,24个月随访结束时为93.7%。
  • 研究期间无致残或非致残性卒中、无再干预、无死亡。

核心结论

  • 单分支 RELAY 支架的结果与文献相比表现良好,作者认为未来用该单分支移植物治疗主动脉病变具有可行性。
  • 作者指出需要更大患者队列的进一步研究来为单分支 RELAY 支架用于主动脉弓手术的可行性积累证据。

研究设计与样本

  • 前瞻性收集并回顾性分析2019年1月至2022年1月来自欧洲各中心的17例接受单分支 RELAY 腔内移植物治疗的患者数据。
  • 随访数据包括术后30天、6个月、12个月和24个月,评估术后结局、靶血管通畅率和再干预率。

主要发现

  • 全部17例患者实现技术成功,技术成功率为100%。
  • 单分支 RELAY 队列中无术后致残性或非致残性卒中。
  • 术后最初30天靶血管通畅率保持100%,至随访结束(24个月)时93.7%的患者实现靶血管通畅。
  • 使用单分支 RELAY 支架的整个研究期间无再干预或死亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要更大患者队列的进一步研究来为单分支 RELAY 支架用于主动脉弓手术的可行性积累证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advances in surgery over the last few decades has led to the development and widespread utilization of thoracic endovascular aortic repair (TEVAR). TEVAR, due to its minimally invasive nature and potential superior outcomes, is now becoming a key focus of interest in treating pathologies of the aortic arch, which has traditionally been treated with open surgical repair. We present our findings of our international multicentre dataset documenting the efficacy of the single-branched RELAY™ endograft in terms of technical success, postoperative outcomes, and reintervention rates. METHODS: Prospective data were collected and retrospectively analyzed with descriptive and distributive analysis between January 2019 and January 2022 from 17 patients treated with RELAY single-branched endoprostheses from centers across Europe. Follow-up data from 30 days and 6 months, 12 months, and 24 months postoperatively was included. Patient follow-up was evaluated in terms of postoperative outcomes, target vessel patency, and reintervention rates. RESULTS: Technical success was achieved in all 17 patients (100%) and there were no postoperative disabling or nondisabling strokes in our single-branched RELAY cohort. The target vessel patency remained 100% during the first 30 days postoperatively; however, by the end of the follow-up period (24 months), target vessel patency was achieved in 93.7% of the patients. There were no reinterventions or deaths during the full study duration using the single-branched RELAY stent-graft. CONCLUSIONS: These results with the single-branched RELAY stent graft demonstrate favorable outcomes in comparison to the literature and demonstrate the feasibility of treatment of aortic pathology with this single-branched graft in the future. Further studies with larger patient cohorts will help us to accumulate evidence for the feasibility of the single-branched RELAY stent graft for aortic arch surgery in the future.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Howard C, Acharya M, Surkhi AO, et al. From the RELAY Family-A Story of Single-Branched International Outcomes. Ann Vasc Surg. 2022. PMID: 36179943. doi:10.1016/j.avsg.2022.09.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。